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Abstract
Background: Type I signal peptidases (SPases) are essential membrane-bound serine proteases
responsible for the cleavage of signal peptides from proteins that are translocated across biological
membranes. The crystal structure of SPase in complex with signal peptide has not been solved and
their substrate-binding site and binding specificities remain poorly understood. We report here a
structure-based model for Escherichia coli DsbA 13–25 in complex with its endogenous type I SPase.
Results: The bound structure of DsbA 13–25 in complex with its endogenous type I SPase
reported here reveals the existence of an extended conformation of the precursor protein with a
pronounced backbone twist between positions P3 and P1'. Residues 13–25 of DsbA occupy, and
thereby define 13 subsites, S7 to S6', within the SPase substrate-binding site. The newly defined
subsites, S1' to S6' play critical roles in the substrate specificities of E. coli SPase. Our results are in
accord with available experimental data.
Conclusion: Collectively, the results of this study provide interesting new insights into the binding
conformation of signal peptides and the substrate-binding site of E. coli SPase. This is the first report
on the modeling of a precursor protein into the entire SPase binding site. Together with the
conserved precursor protein binding conformation, the existing and newly identified substrate
binding sites readily explain SPase cleavage fidelity, consistent with existing biochemical results and
solution structures of inhibitors in complex with E. coli SPase. Our data suggests that both signal
and mature moiety sequences play important roles and should be considered in the development
of predictive tools.
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Background
Translocation across the cell membrane requires the pres-
ence of short signal sequences termed "signal peptides"
that are localized at the amino terminus (N-terminus) of
proteins [1]. These N-termini localized signal peptides are
subsequently removed from the newly synthesized pre-
cursor proteins by type I signal peptidases (SPases) [2].
SPases play essential roles in the viability of bacteria [3,4],
making these enzymes attractive targets for the design of
novel antibiotics [5]. Currently, Escherichia coli is by far
the most widely used host organism for the bacterial
expression of heterologous secreted proteins, especially
for therapeutic purposes, with reported yields of 5–10 g/L
[6]. Mutations in the signal peptide have been known to
affect secretion either by enhancing the processing of the
cleavage site or by inhibiting this proteolytic processing
[7]. It is well known that besides the signal peptide, the N-
terminal region of the mature protein also affects the pro-
tein secretion [8]. We are therefore interested in under-
standing the determinants involved in signal peptide
recognition, binding and cleavage.
The E. coli type I SPase is of particular interest in the study
of type I SPases, as its active site is relatively accessible at
the bacterial membrane surface [5,9-11]. Although many
mutational and biochemical studies have been per-
formed, basic questions such as SPase fidelity and sub-
strate specificity remain unanswered. Signal peptides
exhibit limited primary sequence homology, but are well
conserved at residues positioned -3 (P3) to -1 (P1) relative
to the cleavage site, designated P1-P1' [12]. Comparative
analysis of 36 prokaryotic signal peptides reveals that type
I SPases specifically recognizes substrates with small neu-
tral residues at both the P3 and P1 positions [13]. P3 is
dominated by the presence of alanine, glycine, serine,
threonine and valine; while P1 is characterized by alanine,
glycine, serine and threonine [12,13]. Accordingly, the P3
and P1 positions have been proposed to constitute the
SPase cleavage site and have been actively applied by var-
ious groups for predicting signal peptide cleavage sites
[12,14]. These findings were cited as affirmation of the
location of two key determinants within the signal pep-
tide cleavage site. Unfortunately, no solution structures
exist that can illustrate precisely how the precursor protein
is oriented within the SPase substrate-binding site prior to
proteolysis, or the identity of other critical determinants
that control substrate specificity [15].
In this paper, we report the modeling of an E. coli periplas-
mic dithiol oxidase, DsbA 13–25 in complex with E. coli
type I SPase based on the crystal structures of E. coli SPase
in complex with β-lactam [16] and lipopeptide [17]
inhibitors. The DsbA 13–25 precursor protein was
selected for this study due to its efficient periplasmic secre-
tion [15]. By threading the P7 to P1' positions against the
solved structures of β-lactam [16] and lipopeptide [17]
inhibitors, our model reveals that precursor protein is
bound to E. coli type I SPase with a pronounced twist
between positions P3 and P1'. Thirteen subsites S7 to S6'
were identified that might be critical to these and other
aspects of catalysis. Our model was additionally corrobo-
rated by comparative analysis of 107 experimentally vali-
dated substrates.
Results and discussion
Substrate binding site
The energetically favoured and most frequently populated
bound conformation of DsbA 13–25 H2N-LAFSAS-
AΔAQYEDG-COOH, where the cleavage site is indicated
by Δ [18], to E. coli type I SPase was obtained from our
structural model. The complex defines 13 enzyme sub-
sites, S7 to S6', within the SPase substrate binding site,
interacting with bound precursor SPases. Among these, six
smaller clefts or 'pockets' were identified at subsites S3,
S2, S1, S1', S3' and S4' respectively (Figure 1). The narrow
clefts at S3, S2, S1 and S1' play direct roles in the high spe-
cificity of the signal peptide residues while the larger clefts
at S3' and S4' may be responsible for the specificity of the
mature moieties.
The side chain of Ala19 (P1, Figure 1A) is buried within
the S1 subsite, which is composed of primarily hydropho-
bic and non-polar enzyme residues including the previ-
ously identified Ile86, Pro87, Ser88, Ser90, Met91, Leu95,
Tyr143, Ile144 and Lys145 [9,19]. The S2 subsite (Gln85,
Ile86, Pro87, Ser88, Met91 and Ile144) constitutes the
deepest cavity within the substrate-binding site. This
pocket can accommodate residues with large side chains
and appears to play an important role in substrate specif-
icity of E. coli type I SPase, consistent with biochemical
experiments (discussed in Substrate specificity). This sub-
site, formerly proposed as the S1 subsite by Paetzel et al.
[9,19], largely overlaps with the S1 subsite due to a pro-
nounced twist in the P3 to P1' binding conformation (Fig-
ure 2; detailed in Substrate binding conformation). Our
model reveals that the Ser18 (P2) side chain is not solvent
exposed but is completely buried at this location, due to a
pronounced twist in the P3 to P1' binding conformation
(Figure 2; detailed in Substrate binding conformation). The
S3 subsite, which is composed of non-polar atoms from
residues Phe84, Gln85, Ile86, Pro87, Ile101, Val132,
Asp142 and Ile144 [9,19], is located diagonally across
from the S1 subsite. This pocket constitutes the third
deepest cavity within the substrate-binding site and can
accommodate a wide variety of side chains. The S4 subsite
consisting of Phe84, Gln85, Pro87 and Asp142, is in con-
tact with Ser16 (P4). Further upstream, the S5 subsite is
defined by Phe84, Gln85 and Asp142; S6 consists of
Pro83 and Phe84; while the S7 subsite includes Glu82
and Pro83.BMC Bioinformatics 2008, 9(Suppl 1):S15 http://www.biomedcentral.com/1471-2105/9/S1/S15
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At the P1' to P6' positions of the mature moiety, our
model indicates that the side chains of P1' to P5' residues
are in position to make significant contact with the E. coli
type I SPase. The S1' subsite shares similar residues with
the S1 subsite and includes Ser88, Ser90, Tyr143 and
Ala279. The S2' subsite includes Ser88, Ser90, Phe208,
Asn277 and Ala279. The S3' and S4' subsites constitute a
broad pocket that can accommodate both positive and
negative charged residues by rearrangements of side
chains (Figure 3). The S3' subsite is composed of Met249,
Tyr50, Asp276, Asn277, Ala279, Arg282 and Tyr283,
while the S4' subsite includes Gln244, Asp245, Asp276,
Asn277 and Arg282. Further downstream, the S5' subsite
The E. coli type I signal peptidase substrate-binding site Figure 1
The E. coli type I signal peptidase substrate-binding 
site. Pockets defining the binding site of E. coli type I signal 
peptidase. A) Top view of the molecular surface of E. coli 
SPase binding site (colored blue) with Cα trace of SPase 
(blue lines). Pockets that accommodate signal peptide side 
chains are shown in detail in surrounding views and num-
bered in accordance to their position along the peptide from 
the S1 pocket that contains the active-site nucleophile, 
Ser90. B) Top view of the molecular surface of E. coli SPase 
binding site (colored blue) with the bound conformation of 
DsbA precursor peptide as a CPK model. C) Side view of 
structure in B, rotated by 90°.
A model of the DsbA 13–25 in complex with E. coli SPase Figure 2
A model of the DsbA 13–25 in complex with E. coli 
SPase. A model of the DsbA 13–25 precursor protein (Cα 
trace in black) bound to the active site of E. coli SPase (sche-
matic cartoon diagram in grey) illustrating a pronounced 
twist in the peptide backbone between P3 and P1' at the cat-
alytic site.
The S3'/S4' subsites of E. coli SPase Figure 3
The S3'/S4' subsites of E. coli SPase. Rearrangements of 
side chain residues at S3'/S4' subsites in the crystallographic 
structure of E. coli type 1 SPase (PDB ID: 1B12). A, The side 
chain of Asp276 is exposed to interact with amino acid resi-
dues at positions -3 and -4. B, Rearrangements of Asp276 and 
Arg282 result in a positively charged pocket at S3'/S4' sub-
sites.BMC Bioinformatics 2008, 9(Suppl 1):S15 http://www.biomedcentral.com/1471-2105/9/S1/S15
Page 4 of 7
(page number not for citation purposes)
consists of Phe196, Ser206, Ala243, Asp276 and Asn277,
while the S6' subsite includes Phe196, Ile242 and Ala243.
In our model, the bound precursor protein makes signifi-
cant contact with E. coli SPase I from S7 to S6'. Models
described earlier only focused on the P3-P1' segment and
did not analyze in full the different substrate binding
pockets on either side of the scissile bond. In particular,
the S2 subsite was formerly proposed as the S1 subsite by
Paetzel et al. [9,19] as it largely overlaps with the latter. In
contrast to the analysis by Paetzel et al. [19], our model
reveals that the Ser18 (P2) side chain is not solvent
exposed but is completely buried at this location. The
ability of S3'/S4' to alter their electrostatic requirements
by varying side chain conformations (Figure 3) may help
explain the propensity to find substrates with charged
amino acids at these positions (discussed in detail in Sub-
strate Specificity).
Substrate binding conformation
We have modeled the coordinates of P7 to P1' by thread-
ing against the solved structures of β-lactam [16] and
lipopeptide [17] inhibitors in complex with E. coli SPase,
followed by ab initio docking of the P2' to P6' positions
(for more details, refer Methods). The precursor protein,
DsbA 13–25 is bound to E. coli type I SPase in an extended
conformation with a pronounced backbone twist between
Ala17 (P3) and Ala20 (P1') (Figure 2). In the P3-P1' seg-
ment, the first three side chains are all oriented towards
the binding groove, and only the P1' side chain oriented
across the binding groove. As shown in Figure 4, similar
interactions between the E. coli type 1 SPase with DsbA
13–25 model, lipopeptide inhibitor (PDB ID: 1T7D) and
β-lactam inhibitor (PDB ID: 1B12) were observed. The
conformation of P3' and P4' allow their corresponding
side-chains to extend into a large cavity (S3'/S4' subsite;
Figure 1). As such, medium or large residues are preferred
at these two positions for favorable interactions. Good
agreement with the known experimental data (refer Sub-
strate Specificity) is obtained, supporting the validity of
our model.
Ten positions for hydrogen bonding were identified sup-
porting high affinity binding between E. coli SPase and
DsbA 13–25. These include Ser18 (P2) O...Ser88 NH,
Ser18 (P2) O...Ser88 OG, Ala19 (P1) N...Ser88 OG, Gly89
N...Gln21 (P2') OE1, Ala19 (P1) N...Ser90 OG, Ser90
OG...Ala20 (P1') O, Lys145 NZ...Ala19 (P1) O, Gln194
NE2...Asp24 (P5') OD2, Ser206 OG...Asp24 (P5') OD2
and Arg282 NH1...Glu23 (P4') OE1. Our model suggests
that the enzyme-substrate contact points extend all the
way from P7 to P6' of the DsbA precursor protein.
The orientation of DsbA 13–25 side chains within the
active site (P7-P6') of E. coli SPase adopts the pattern [20]:
↓ ￿ ￿ ￿ ↓ ↓ ↓ ￿ ￿ ↓ ↓ ￿ ￿ (where ↓ represents a side chain
oriented towards the binding site and ￿ represents a side
chain oriented away or across the binding site). Specifi-
cally, the P3-P1' segment adopts the pattern: ↓ ↓ ↓ ￿, with
the side chains of P3, P2 and P1 oriented towards the
binding groove thereby supporting the stringent selectiv-
ity criteria in this region. The side chain of P1' alone is ori-
ented differently, in accord with the observed variability
in this position. A similar conformation was obtained for
the precursor sequence OmpA 15–27 [21,22] H2N-
FATVAQAΔATSTKK-COOH (P1-P1' cleavage site indi-
cated by Δ) in complex with E. coli type 1 SPase (data not
shown). Here again, the P3-P1' side chains of OmpA
adopt the orientation ↓ ↓ ↓ ￿, while the model proposed
by Paetzel et al. [19] and Ekici et al. [22], adopts the pat-
tern  ↓ ￿ ↓ ￿, with the side chain of P2 not pointing
towards the binding groove. The disparity between our
model and Paetzel et al. [19] may be attributed to the
selection of different template structures where the struc-
Superimposition of DsbA 13–25 precursor protein with  lipopeptide and β-lactam inhibitors Figure 4
Superimposition of DsbA 13–25 precursor protein 
with lipopeptide and β-lactam inhibitors. A model of 
the DsbA 13–25 precursor protein (red) bound to the active 
site of E. coli type 1 SPase (grey). Superimposition of the P7 
to P1' positions of DsbA precursor protein with the lipopep-
tide (blue; PDB ID: 1T7D) and β-lactam (yellow; PDB ID: 
1B12) inhibitors from A, top view and B, side view respec-
tively. Residues N-terminal to P7 and C-terminal to P2' have 
been truncated for clarity.BMC Bioinformatics 2008, 9(Suppl 1):S15 http://www.biomedcentral.com/1471-2105/9/S1/S15
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tures of the covalently bound peptide inhibitor complex
and the analogous enzyme LexA were used to guide the P1
and P3 to P6 positions of the later [19], while the coordi-
nates of P7 to P1' for our model were guided by the solved
structures of β-lactam [16] and lipopeptide [17] inhibitors
in complex with E. coli SPase. In our models, the P2 side
chains in the bound DsbA and OmpA models are hydro-
gen-bonded to the catalytically important SPase I residue,
Ser88 [23]. The twist in the backbone conformation in the
region P3-P1' is representative of the transition state, with
three critical hydrogen bonds conserved in our model and
the bound β-lactamase and lipoprotein inhibitors, with
the atoms Ser88 Oγ, Ser90 Oγ and Lys145 Nζ important
for catalytic activity.
Substrate specificity
We were interested in understanding how the peptides
modeled in this study reflect the E. coli repertoire of
secreted signals. Comparative analysis of 107 experimen-
tally determined E. coli type I SPase substrates (Figure 5)
revealed high conservation of amino acid residues at posi-
tions P3 and P1. In particular, position P1 is dominated
by small (99%), hydrophobic (98%), and neutral (100%)
residues, with alanine being the predominant residue
(92% or 98/107) at this position, followed by glycine
(9%). Position P2 shows a strong preference for bigger
side chains with 87% (93/107) possessed by medium- or
large-sized residues at this location. Position P3 also
shows a preference for hydrophobic residues (83%).
Although this position contains mainly small amino acid
residues (61%), it can also accommodate both medium
(25%) and large (14%) residues. Only 50% (54/107) of
the sequences contain the consensus Ala-X-Ala recogni-
tion motif, while even fewer sequences (18%; 19/107)
contain a Val-X-Ala recognition sequence. In our modeled
structure for DsbA propeptide, the side chains from P7 to
P4 are also in positions to make substantial contacts with
SPase (Figure 2), but are not confined to 'pockets'. None-
theless, these residues may also participate in binding by
interacting with surface residues of SPase. These observa-
tions are in accord with the lack of residue preference
observed in these positions (Figure 5). Overall, in the 107
signal peptide dataset, neutral residues (≥98%) are pre-
ferred in positions P7 to P1, indicating that charged inter-
actions between signal peptides and E. coli type I SPase are
disfavored in this stretch, consistent with earlier reports
on the carboxy-terminus of the C-region [24]. However,
few signal sequences possess polar residues at the C-
region (P7: 17%; P6: 48%; P5: 30%; P4: 52%; P3: 18%;
P2: 41%; P1: 2%), in contrast with earlier studies [24,25].
Most residues are tolerated at the +1 (P1') position of the
mature moiety, with the exception of the large hydro-
phobes, Ile, Met, Trp, Pro and Arg. Here, Pro is disfavored
as the rigid positioning of its backbone hinders docking
interactions with SPase at positions P2' to P6'. The major-
ity of E. coli signal peptides contain medium or large resi-
dues both at P3' (81%) and at P4' (90%) positions. The
propensity for negatively charged residues to occur at P3'
and P4' positions are low, with observed values of 10%
(or 11/107) and 19% (or 20/107) respectively, while 8%
(9/107) and 13% (14/107) respectively of the sequences
analyzed have positively charged residues at these posi-
tions.
Conclusion
We have developed a structural model for E. coli SPase I
complex, with bound DsbA and OmpA propeptides, con-
sistent with existing biochemical data and solution struc-
tures of E. coli type I SPase-inhibitor complexes [16,17].
The developed models provided an opportunity to exam-
ine the bound structure of E. coli type I SPase complex that
have been difficult to solve experimentally. It appears that
both signal and mature moiety sequences play direct role
in catalysis. This work advances our understanding of the
molecular mechanism governing signal peptide specifici-
ties and SPase fidelity, it also serves as a useful guide for
designing suitable signal and mature peptide sequences
for enhancing heterologous protein expression using E.
coli as the host organism.
Methods
Precursor protein sequence data
The SPdb database [26]http://proline.bic.nus.edu.sg/
spdb/ was used as a source for the E. coli type I SPase sub-
strates. A set of 107 precursor protein sequences was
extracted and used in the current analysis where sequences
with 80% sequence identity were extracted using the CD-
HIT software [27] to reduce redundancy and bias [28].
Analysis of E. coli signal sequences Figure 5
Analysis of E. coli signal sequences. Sequence logo [35] 
illustrating the size (small: green; medium: blue; large: red) of 
amino acids at different positions along the precursor pro-
teins of 107 experimentally verified E. coli signal sequences 
from SPdb, showing A, the end of the signal peptide (P7-P1) 
and B, the start of the mature moiety (P1'-P6').BMC Bioinformatics 2008, 9(Suppl 1):S15 http://www.biomedcentral.com/1471-2105/9/S1/S15
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Crystallographic data
The atomic coordinates of E. coli type I SPase were
extracted from the Protein Databank (PDB) entry 1B12
[16] which has a 1.95 Å resolution structure. Atomic coor-
dinates for E. coli type I SPase-bound β-lactam [16] and
lipopeptide [17] inhibitors were retrieved from PDB
entries 1B12 and 1T7D respectively. The structures were
relaxed by conjugate gradient minimization, using the
Internal Coordinate Mechanics (ICM) software package
[29].
Substrate modeling
The coordinates for the P7 to P1' positions of DsbA 13–25
were obtained by threading against the crystallographic
structures of E. coli type I SPase-bound inhibitors [16,17].
The P7 to P3 positions were taken from the structure of E.
coli type I SPase-bound lipopeptide inhibitor [17] by sub-
stituting the atoms N1, C2, C5, O6, N7, C8, C10, O11,
N12, C13, C14, O15, N16, C18, C26, O27, N28, C29,
C31, O32 and N33 with DsbA 13–17 main-chain atoms;
while coordinates for the P2 to P1' positions were guided
by the solution structure of the E. coli type I SPase-bound
β-lactam [16] inhibitor based on the atoms N4, C5, C6,
C3, C9, O10, C15, C16, O17, C18, O19, C20. A flexible
docking using biased Monte-Carlo procedure [29-31] that
incorporates the Rapid Exact-Boundary ELectrostatics
(REBEL) algorithm for evaluation of the electrostatic sol-
vation energy [32] was subsequently performed to sample
different conformations and orientations of P2' to P6'
positions with respect to the receptor. In each iteration, a
random move in the P2' to P6' positions of the ligand was
performed and new conformations were selected based
on the Metropolis criterion with a temperature of 5000 K
[31,33]. The simulation was terminated after 20,000
energy evaluations [31] and the results analyzed for con-
sistency.
Intermolecular hydrogen bonds
The number of intermolecular hydrogen bonds was calcu-
lated using HBPLUS [34] in which hydrogen bonds are
defined in accordance with the standard geometric param-
eters.
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